<乌鸦传媒>Myeloablative Therapy Prevails in AML Transplant Study Better survival, fewer relapses compared with reduced-intensity conditioning Feb 21, 2020
<乌鸦传媒>Better Quality CR With One AML Therapy vs Another? Longer survival after CR/CRi with CPX-351 than with 7+3 in patients with AML-MRC Feb 21, 2020
<乌鸦传媒>Gains in Stem Cell Transplant Mortality Over Last 25 Years But outcomes still "far from perfect" Jan 20, 2020
<乌鸦传媒>What Is Causing This Woman's Swollen Chin? A long and challenging diagnostic path with twists and turns Jan 20, 2020
<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers Vaccine development may help with prevention of herpes zoster in this population Dec 31, 2019
<乌鸦传媒>'Dark Waters': Behind-the-Scenes With Attorney Who Took on DuPont Chemical in Teflon was "completely unregulated" when Robert Bilott went after corporate giant Dec 19, 2019
<乌鸦传媒>Denosumab Use in Myeloma Soars for No Obvious Reason More expensive than competitor without being better, so why does it now have nearly half the market? Dec 12, 2019
<乌鸦传媒>Survival Bump With Oral AML Maintenance Ten-month OS gain, doubling of RFS with oral azacitidine in transplant-ineligible patients Dec 10, 2019
<乌鸦传媒>'Off-the-Shelf' Therapy Active After CAR T-Cell Failure Bispecific antibody mosunetuzumab targets CD3, CD20; needs no ex vivo T-cell processing Dec 07, 2019
<乌鸦传媒>Study Bolsters Case for Novel Xarelto Formulation for Kids Pharmacokinetic data indicate appropriate dosing schemes across wide range of weight categories Dec 07, 2019
<乌鸦传媒>IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR Prognostic tool may predict who is likely to achieve a relatively long remission Oct 15, 2019
<乌鸦传媒>FCR Still an Option in IGHV-Unmutated CLL? Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit Oct 08, 2019
<乌鸦传媒>Ibrutinib's Cardiotoxicity Comes Into Focus Study identifies new cardiac events linked to so-called targeted therapy Sep 25, 2019
<乌鸦传媒>Red Cell Distribution Width Strongly Predicts Hip Fracture Simple way to identify at-risk patients Sep 24, 2019
<乌鸦传媒>Could Mom's Anemia Hurt Baby's Brain? Association study suggests an increased risk, though still quite small Sep 18, 2019
<乌鸦传媒>Good News, Bad News for CRISPR Gene Editing for HIV Cure "Bigger story for the gene-editing field than the HIV field" Sep 11, 2019
<乌鸦传媒>Serum Immune Markers May Predict Conversion From MGUS to Myeloma Results could support annual blood tests and risk assessment for those with MGUS and its subtype, light-chain MGUS Jul 19, 2019
<乌鸦传媒>TAVR Access Closure Devices Not Equal, Study Shows Separate study suggests bleed monitoring device could help May 23, 2019
<乌鸦传媒>Enoxaparin May Be Underdosed for CRC Surgery Patients Standard dose yielded low anticoagulation levels in 68% but no increase in venous thromboembolism May 23, 2019
<乌鸦传媒>Rheumatologist's Primer on Checkpoint Inhibitors Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<乌鸦传媒>Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time? Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
<乌鸦传媒>Durable Responses With Keytruda in Later-Line SCLC Plus umbralisib in marginal zone lymphoma and a next-generation TRK-targeted agent Apr 04, 2019
<乌鸦传媒>Overall Survival Data in for Gilteritinib as AML Salvage Tx FLT3 Inhibitor tops chemotherapy in randomized trial Apr 01, 2019
<乌鸦传媒>Transplant No Help in Hypodiploid ALL Similar 5-year outcomes with or without HSCT, regardless of MRD status Mar 29, 2019
<乌鸦传媒>Are Patients Better Off With Image-Guided Bone Marrow Biopsy? Prospect of sedation has some going to interventional radiology Mar 29, 2019
<乌鸦传媒>Ticagrelor Antidote Clears Phase I Trial Quick reversal of P2Y12 inhibitor possible in healthy participants Mar 17, 2019
<乌鸦传媒>Andexanet Holds Strong as Antidote to Apixaban, Rivaroxaban Reversal agent for factor Xa inhibitors soon to be subject to a randomized trial Feb 08, 2019
<乌鸦传媒>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers Vaccine development may help with prevention of herpes zoster in this population Dec 14, 2018
<乌鸦传媒>ASH Poster Rounds: Adding BTK Inhibitor Safe in First-Line MCL Plus: Lenalidomide upfront in PTCL; skipping RT in primary mediastinal B-cell lymphoma Dec 07, 2018
<乌鸦传媒>ASH Poster Rounds: Obesity Impacts CLL Survival in Women Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib Dec 06, 2018
<乌鸦传媒>Cancer-VTE Trial Falls Short High dropout rate undermines rivaroxaban prophylaxis trial Dec 05, 2018
<乌鸦传媒>Combination Regimen Extends PFS in Myeloma Large benefit but relevance of comparator questioned Dec 04, 2018
<乌鸦传媒>$2 Test Could Transform Sickle Cell Dx in Africa May have applications in high-income countries as well Dec 04, 2018
<乌鸦传媒>ASH Offers Early Look at Updated SCD Guidelines Experts formulated >50 recommendations on sickle cell disease Dec 03, 2018
<乌鸦传媒>CAR T-Cell Responses Prove Durable in ALL, DLBCL Two studies demonstrate long-term control in relapsed/refractory disease Dec 01, 2018
<乌鸦传媒>Sneak Peek at Practice-Changing Research From ASH 2018 "Big trials, big results," plus sickle cell disease and CAR T-cell therapies Nov 30, 2018
<乌鸦传媒>LMWH Prevails for VTE Prevention in Guideline ASH unveils first six chapters of comprehensive recommendations Nov 29, 2018
